Skip to content

Author

O. Abiodun

6 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Global and regional burden of measles and vaccine coverage among children under 5 years, 1990−2023: a Global Burden of Disease Study

Measles remains a leading cause of vaccine-preventable burden among children, particularly in low-income settings. Despite decades of progress, there are indications of measles resurgence due to stagnation in vaccine coverage. Here, using the Global Burden of Diseases, Injuries and Risk Factors Study (GBD) 2023, we sys...

B. Sartorius, Noga Shalev, I. Poudyal et al. · 4 citations
Open access Nov 2026

Global, regional and national burden of cervical cancer in 1990-2023 with forecasts to 2050: a Global Burden of Disease study.

Age-standardized incidence rate (ASIR) and age-standardized mortality rates (ASMR) were more than four and seven times higher in low- versus high-income countries, and are forecast to remain highest in low-income countries.

Natalie Pritchett, Miranda L. May, Jonathan M. Kocarnik et al. · 0 citations
Review Open access Aug 2026

Global, regional, and national burden of HIV/AIDS, 1990-2023, with the estimated burden attributable to intimate partner violence and forecasted impacts of funding cuts through 2030: results from the Global Burden of Disease Study 2023.

This study aimed to quantify recent trends in the HIV burden, the magnitude of the HIV burden associated with IPV, and the potential impact of declining financial support globally, and to estimate how funding levels could affect antiretroviral therapy (ART) coverage.

A. Carter, Meixin Zhang, B. Trejo et al. · 1 citation
Review Open access Sep 2026

Global, regional, and national burden of exposure to chewing tobacco, 1990-2023: a systematic analysis of the Global Burden of Disease Study 2023.

BACKGROUND Exposure to chewing tobacco is a known health risk factor but has received less attention than smoking in global tobacco control efforts. As the evidence base linking chewing tobacco use to poor health grows, it is essential to closely track the changing use of chewing tobacco distinct from other forms of sm...

G. Gil, Jason A. Anderson, Xiao-Chen Dai et al. · 1 citation
Review Open access Sep 2026

Burden of non-communicable diseases and their attributable risk factors in Africa from 1990 to 2023: a systematic analysis for the Global Burden of Disease Study 2023

Summary Background The rapid rise in the burden of non-communicable disease (NCDs) in African communities has resulted in a considerable mortality, disability, and economic burden. A comprehensive evaluation of incidence, deaths, disability-adjusted life-years (DALYs), and attributable risk factors related to NCDs by s...

A. Awedew, Mihretu Jegnie, K. Abate et al. · 2 citations
Review Open access Sep 2026

Global, regional, and national prevalence of second-hand smoke and attributable disease burden in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

It is estimated that SHS remains a substantial driver of global health loss, particularly through cardiovascular and paediatric respiratory diseases, and growing absolute numbers of exposed individuals in several regions underscore the urgent need for accelerated implementation and enforcement of comprehensive tobacco...

L. Flor, Jason A. Anderson, Brooks W. Morgan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.